I. Project name: Project towards investment promotion of Shandong Zhongsheng Pharmaceutical Co., Ltd.

II. Project address: Chuangye Street of Taishan Industrial Park

III. Brief introduction to the project: This company covers an area of 60 Chinese acres with a building area of 23,000 square metres, among which, the manufacturing workshops covers an area of 17,000 square metres and the office building covers an area of 600 square metres. The company which mainly trades in the proprietary Chinese medicine, possess 4 dosage form (injection, oral liquid, granular formulation, troche) more than 50 varieties. The company is going to expand the scale of production by introucing the capital or cooperating with other pharmaceutical factories. Investors are welcome to negotiate and cooperate with the company.

IV. Total investment: 50 million yuan RMB

V. Ways of cooperation: Joint venture and cooperation

VI. Market analysis of the project: Shandong Zhongsheng Pharmaceutical Co., Ltd. takes the TCMI as their flagship product, 6 products of the TCMI have been listed in the fingerprint catalog of TCMI (there are 74 in all in China). The company has formed the nature medicine operation strategy by implementing objective management and leading in the CIS recognition system. Therefore, this project has a wide market development space.

VII. Analysis of the economic benefit: After the project puts into operation, it can newly increase the sales revenue of 60 million yuan RMB, and profit and tax of 10 million yuan RMB annually as well.

VIII. Contact ways:
Contact unit: Taishan District Investment Promotion Bureau
Person to contact: Wang Hu, Di Huixia
Tel: 0086-538-6269809/6262867
E-mail: tsqzsj@163.com